17.12.14.Cynata Receives $1.3m R&D Tax Incentive Refund
(WorldNews Health)

ASX ANNOUNCEMENT 14 December 2017 Cynata Receives $1.3m R&D Tax Incentive Refund Melbourne, Australia; 14 December 2017: Australian stem cell and regenerative medicine company, Cynata Therapeutics Limited (ASX: CYP), is pleased to announce that the Company has received a A$1,328,649 R&D Tax Incentive Refund for the 2016/2017 financial year. The Tax Incentive Refund further bolsters the Company`s cash position and extends its operating runway into...